2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions

View by Date

Wednesday, September 25, 2019

1:15pm-2:45pm: Data quality, acceptability and reliability of the Movement Disorders Society – Non Motor Rating Scale (MDS-NMS)

C. Rodriguez-Blazquez, A. Schrag, D. Weintraub, A. Rizos, KR. Chaudhuri, P. Martinez-Martin (Madrid, Spain)

Non-Motor Symptoms · Agora 3 West, Level 3

1:15pm-2:45pm: Day Hospitals Reinvented : the future of Parkinson’s care

J. Adenwalla, S. Jones, M. Oliver, N. Noushad, B. Mohamed, C. Thomas, T. Williams, S. Mahon (Cardiff, United Kingdom)

Phenomenology and Clinical Assessment of Movement Disorders · Les Muses Terrace, Level 3

1:15pm-2:45pm: DBS for Parkinson-Dementia syndrome: Stimulation of both Globus Pallidus internus & the Nucleus Basalis of Meynert using the same electrode lead

C. Nombela, A. Lozano, C. Villanueva-Iza, J. Barcia (Madrid, Spain)

Cognition and Cognitive Disorders · Agora 3 East, Level 3

1:15pm-2:45pm: DBS for PD in Albania

I. Zekja, R. Alimehmeti, F. Dashi, S. Grabova, M. Petrela, M. Rralacolli, J. Kruja (Tirana, Albania)

Non-Pharmacological Interventions · Les Muses Terrace, Level 3

1:15pm-2:45pm: DBS in Parkinson’s disease: Experience from Egypt

A. Mansour, Z. Fayed (Cairo, Egypt)

Surgical Therapy · Les Muses Terrace, Level 3

1:15pm-2:45pm: Deceleration capacity of heart rate: is cardiac vagal modulation impaired in idiopathic Parkinson’s disease?

C. Carricarte Naranjo, C. Marras, N. Visanji, D. Cornforth, L. Sanchez-Rodriguez, B. Schüle, S. Goldman, M. Estevez, P. Stein, A. Lang, H. Jelinek, A. Machado (La Habana, Cuba)

Non-Motor Symptoms · Agora 3 West, Level 3

1:15pm-2:45pm: Decline in Neural Connectivity in Olfactory Spatial Attention: A Comparative Study in the Progression of Parkinson’s Disease

H. Chatterjee, G. Elumalai, N. Osakwe, N. Sewram (Georgetown, Guyana)

Neuroimaging · Les Muses Terrace, Level 3

1:15pm-2:45pm: Decreased baroreflex sensitivity in Parkinson’s disease is associated with orthostatic hypotension

P. Turcani, P. Valkovic, P. Siarnik, S. Sutovsky (Bratislava, Slovakia)

Non-Motor Symptoms · Agora 3 West, Level 3

1:15pm-2:45pm: Decreased Cannabinoid Type 1 Receptor Density in Parkinson’s Disease: A [18F]FMPEP-d2 PET Study

A. Brück, H. Al-Abdulrasul, J. Tuisku, R. Ajalin, J. Hirvonen, J. Rinne (Turku, Finland)

Neuroimaging · Les Muses Terrace, Level 3

1:15pm-2:45pm: Deep Brain Stimulation (DBS) in Pantothenate Kinase-Associated Neurodegeneration (PKAN): An Experience in a Thai Patient

P. Termsarasab, P. Boonkongchuen, T. Pulkes, O. Trachoo, A. Boongird (Bangkok, Thailand)

Surgical Therapy · Les Muses Terrace, Level 3